Abstract
Purpose
Only a few reports in the literature have investigated the presence of ocular abnormalities in neurofibromatosis type 1 (NF-1) patients. The aim of this study was to evaluate the prevalence of ocular abnormalities in a large population of NF1 patients, focusing on the choroidal changes.
Methods
This study was conducted on 160 consecutive patients with NF1 and 106 sex- and age-matched healthy subjects (control). Each patient underwent a complete ophthalmological examination inclusive of best-corrected visual acuity, intraocular pressure measurement, slit-lamp biomicroscopy, indirect fundus biomicroscopy, and near-infrared reflectance (NIR) retinography by using the spectral domain OCT. Moreover, all patients underwent complete dermatological exam and 1.5-Tesla MRI scan of the brain to assess the presence of optic nerve gliomas.
Results
Choroidal abnormalities were detected in 97% of patients, with a positive predictive value of 100% and a negative predictive value of 96.4%. Interestingly, a small number of patients (4/160; 2.5%) showed Lisch nodules without choroidal abnormalities, whereas a larger number of patents (22/160; 13.75%) presented choroidal lesions in absence of Lisch nodules. None of the patients showed the absence of both choroidal lesions and Lisch nodules. The number of choroidal lesions increased with age (r = 0.364, p = 0.0001) and with the severity of pathology (r = 0.23, p = 0.003). Any statistically significant correlation between choroidal lesions, visual acuity, and intraocular pressure was observed.
Conclusions
NIR imaging represents an in vivo, non-invasive, sensitive and reproducible exam to detect choroidal nodules in NF-1 patients, suggesting that choroidal changes may represent an additional diagnostic criteria for NF1.
Similar content being viewed by others
References
Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15(5):290–301. https://doi.org/10.1038/nrc3911
Richetta A, Giustini S, Recupero SM, Pezza M, Calvieri S (2004) Lisch nodules of iris in Neurofibromatosis type 1. J Eur Dermatol Venerol 18(3):342–344. https://doi.org/10.1111/j.1468-3083.2004.00915.x
Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13(8):834–843. https://doi.org/10.1016/S1474-4422(14)70063-8
Kurosawa A, Kurosawa H (1982) Ovoid bodies in choroidal neurofibromatosis. Arch Ophthalmol 100(12):1939–1941
Yasunari T, Shiraki K, Hattori H, Miki T (2000) Frequency of choroidal abnormalities in neurofibromatosis type 1. Lancet 356(9234):988–992. https://doi.org/10.1016/S0140-6736(00)02716-1
Byun YS, Park YH (2012) Indocyanine green angiographic findings of obscure choroidal abnormalities in neurofibromatosis. Korean J Ophthalmol 26(3):230–234. https://doi.org/10.3341/kjo.2012.26.3.230
Parrozzani R, Clementi M, Frizziero L, Miglionico G, Perrini P, Cavarzeran F et al (2015) In vivo detection of choroidal abnormalities related to NF1: feasibility and comparison with standard NIH diagnostic criteria in pediatric patients. Invest Ophthalmol Vis Sci 56(10):6036–6042
Vagge A, Camicione P, Capris C, Sburlati C, Panarello S, Calevo MG et al (2015) Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population. Acta Ophthalmol 93:e667–e671
National Institute of Health Consensus Development (1988) Neurofibromatosis. Conference statement. Arch Neurol 45:575–578
Wallace MR (2000) Neurofibromatosis: phenotype, natural history, and pathogenesis. Am J Hum Genet 67(1):264
Nakakura S, Shiraki K, Yasunari T, Hayashi Y, Ataka S, Kohno T et al (2005) Quantification and anatomic distribution of choroidal abnormalities in patients with type I neurofibromatosis. Graefes Arch Clin Exp Opthalmol 243(10):980–984
Viola F, Villani E, Natacci F, Selicorni A, Melloni G, Vezzola D et al (2012) Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1. Ophthalmology 119(2):369–375
Tadini G, Milani D, Menni F, Pezzani L, Sabatini C, Esposito S (2014) Is it time to change the neurofibromatosis 1 diagnostic criteria? Eur J Intern Med 25(6):506–510
Naumann GOH, Apple DJ (1980) Uvea, pathology of the eye. Springer-Verlag, New York
Makino S, Tampo H (2013) Optical coherence tomography imaging of choroidal abnormalities in neurofibromatosis type 1. Case Rep Ophthalmol Med 2013:292981
Ueda-Consolvo T, Miyakoshi A, Ozaki H, Houki S, Hayashi A (2012) Near-infrared fundus autofluorescence-visualized melanin in the choroidal abnormalities of neurofibromatosis type 1. Clin Ophthalmol 6:1191–1194
Ayata A, Unal M, Ersanli D, Tatlipinar S (2008) Near-infrared fluorescence and OCT features of choroidal abnormalities in type 1 neurofibromatosis. Clin Exp Ophthalmol 36(4):390–392
Makino S, Tampo H, Arai Y, Obata H (2014) Correlations between choroidal abnormalities, Lisch nodules, and age in patients with neurofibromatosis type 1. Clin Ophthalmol 8:165–168
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no financial interest in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee o Sapienza University of Rome and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Moramarco, A., Giustini, S., Nofroni, I. et al. Near-infrared imaging: an in vivo, non-invasive diagnostic tool in neurofibromatosis type 1. Graefes Arch Clin Exp Ophthalmol 256, 307–311 (2018). https://doi.org/10.1007/s00417-017-3870-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-017-3870-z